Your browser doesn't support javascript.
loading
Adjuvants in influenza vaccines.
Tetsutani, Kohhei; Ishii, Ken J.
Afiliação
  • Tetsutani K; Laboratory of Adjuvant Innovation, National Institute of Biomedical Innovation, Japan.
Vaccine ; 30(52): 7658-61, 2012 Dec 14.
Article em En | MEDLINE | ID: mdl-23084848
ABSTRACT
The effectiveness of influenza vaccines is still controversial, and the role of adjuvants in such vaccines is briefly reviewed in this paper. Inactivated whole virus vaccines may include components that function as adjuvants, meaning that additive adjuvants are often not required. MF59 and AS03 showed higher adjuvanticity than aluminum salts in several clinical studies. Recent research has suggested that immune cell recruitment is the main mechanism underlying adjuvant actions in general, and that aluminum salts induce this recruitment via inflammation at the injected site. The aspect of how oil-based adjuvants, such as MF59 and AS03, recruit immune cells remains to be clarified.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Adjuvantes Imunológicos Idioma: En Revista: Vaccine Ano de publicação: 2012 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Adjuvantes Imunológicos Idioma: En Revista: Vaccine Ano de publicação: 2012 Tipo de documento: Article País de afiliação: Japão